{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:04:08Z","timestamp":1793412248559,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA254564"],"award-info":[{"award-number":["U54CA254564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43CA260641"],"award-info":[{"award-number":["D43CA260641"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01TW011470"],"award-info":[{"award-number":["K01TW011470"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Global Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bglo.2025.100021","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:17:13Z","timestamp":1753741033000},"page":"100021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries"],"prefix":"10.1016","volume":"1","author":[{"given":"Dalton M.","family":"Craven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1845-6577","authenticated-orcid":false,"given":"Meagan J.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-7994","authenticated-orcid":false,"given":"Griffin M.","family":"Sansbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarsizious","family":"Chikaonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marriam","family":"Mponda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire T.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3023-1382","authenticated-orcid":false,"given":"Karen S.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9175-7436","authenticated-orcid":false,"given":"Matthew S.","family":"Painschab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bglo.2025.100021_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.bglo.2025.100021_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.bglo.2025.100021_bib3","series-title":"Hodgkin Lymphoma","author":"Kaseb","year":"2025"},{"issue":"12","key":"10.1016\/j.bglo.2025.100021_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000971","article-title":"CAR-T cell therapy for classical Hodgkin lymphoma","volume":"7","author":"Katsin","year":"2023","journal-title":"HemaSphere"},{"issue":"1","key":"10.1016\/j.bglo.2025.100021_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 global burden of disease study","volume":"12","author":"Zhou","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"6","key":"10.1016\/j.bglo.2025.100021_bib7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/GO.20.00088","article-title":"Treatment of Hodgkin lymphoma with ABVD chemotherapy in rural Rwanda: a model for cancer care delivery implementation","volume":"6","author":"DeBoer","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.bglo.2025.100021_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102480","article-title":"Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort study","volume":"69","author":"Mponda","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"22","key":"10.1016\/j.bglo.2025.100021_bib9","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2012-02-387092","article-title":"Meeting the challenge of hematologic malignancies in sub-Saharan Africa","volume":"119","author":"Gopal","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bglo.2025.100021_bib10","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bglo.2025.100021_bib11","author":"Hamadeh"},{"issue":"1","key":"10.1016\/j.bglo.2025.100021_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1267080","article-title":"Loss to follow-up","volume":"2","author":"Dettori","year":"2011","journal-title":"Evid Based Spine Care J"},{"issue":"5","key":"10.1016\/j.bglo.2025.100021_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ijc.31096","article-title":"Lower socioeconomic status is independently associated with shorter survival in Hodgkin lymphoma patients\u2014an analysis from the Brazilian Hodgkin lymphoma registry","volume":"142","author":"Biasoli","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bglo.2025.100021_bib17","article-title":"Clinical characteristics and histopathological patterns of Hodgkin lymphoma and treatment outcomes at a tertiary cancer center in Ethiopia","volume":"7","author":"Adam","year":"2021","journal-title":"JCO Glob Oncol"},{"issue":"4","key":"10.1016\/j.bglo.2025.100021_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2206125","article-title":"Overall survival with brentuximab vedotin in stage III or IV Hodgkin\u2019s lymphoma","volume":"387","author":"Ansell","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.bglo.2025.100021_bib19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/15384047.2020.1796194","article-title":"Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database","volume":"21","author":"Wang","year":"2020","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"10.1016\/j.bglo.2025.100021_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10428194.2016.1193856","article-title":"Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma","volume":"58","author":"Son","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"10.1016\/j.bglo.2025.100021_bib22","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1001\/jama.283.19.2579","article-title":"Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care","volume":"283","author":"Fiscella","year":"2000","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.bglo.2025.100021_bib23","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"10.1016\/j.bglo.2025.100021_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.hemonc.2019.05.003","article-title":"Special report: summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) Group, Casablanca, Morocco, April 19-21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT)","volume":"13","author":"Harif","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.bglo.2025.100021_bib25","first-page":"33","article-title":"Why and how should Ethiopia establish a stem cell transplant service? A review article","volume":"17","author":"Mekonnen","year":"2023","journal-title":"Biologics"},{"issue":"7","key":"10.1016\/j.bglo.2025.100021_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.2020005469","article-title":"Hematologic cancers in individuals infected by HIV","volume":"139","author":"Carbone","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bglo.2025.100021_bib27","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","article-title":"Epidemiology of haematological malignancies in people living with HIV","volume":"7","author":"Kimani","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.bglo.2025.100021_bib28","article-title":"HIV and Hodgkin lymphoma survival: a prospective study in Botswana","volume":"8","author":"Moahi","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"10.1016\/j.bglo.2025.100021_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00277-018-3533-0","article-title":"Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration","volume":"98","author":"Swart","year":"2019","journal-title":"Ann Hematol"},{"issue":"33","key":"10.1016\/j.bglo.2025.100021_bib30","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.bglo.2025.100021_bib31","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bglo.2025.100021_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(23)00318-2","article-title":"Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis","volume":"24","author":"Ehrlich","year":"2023","journal-title":"Lancet Oncol"}],"container-title":["Blood Global Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050565825000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050565825000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:59:38Z","timestamp":1779681578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050565825000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S3050565825000216"],"URL":"https:\/\/doi.org\/10.1016\/j.bglo.2025.100021","relation":{},"ISSN":["3050-5658"],"issn-type":[{"value":"3050-5658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Blood Global Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bglo.2025.100021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100021"}}